From The Web / Gout medication reduces major cardiovascular events in heart patients
Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.
Read the Original Article>>
Source: News Medical Life Sciences
Forgot your password?
You are one step away from accessing the latest educational resources from Healthed.
I have read and agree to Healthed's Terms of Use and Privacy Policy, and confirm that I am a healthcare professional.
By joining Healthed you will receive communications intended to help you stay up-to-date and assist you in providing expert care in the increasingly demanding field of medicine. You can update your preferences at any time via the link at the bottom of any email you receive from us or by contacting us directly.
Back to login screen
expert
